Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q4 FY23 Earnings Presentation
26 slides from Apollo Hospitals Enterprise's earnings presentation, May 30, 2023
Slide 1: Apollo Hospitals Enterprise Limited - Regulation 30 Disclosure
BS Ag APOLLO HOSPITALS ENTERPRISE LIMITED Apollo CIN : L85110TN1979PLC008035 HOSPITALS TOUCHING LIVES 30" May 2023 The Secretary, The Secretary, The Manager Bombay Stock Exchange Ltd (BSE) National Stock Exchange, The National Stock Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Exchange, Da
Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q4 FY23
APOLLO HOSPITALS ENTERPRISE LIMITED Earnings Update Q4 FY23
Slide 3: Agenda
EE <-> !iishlishts x 01 Highlights 02 Financials 03 Healthcare Services 04 Diagnostics & Retail 05 Digital Health 06 Annexure Health & Pharmacy Distribution SE
Slide 4: Highlights
> a Di Q ' HIGHLIGHTS ! ys
Slide 5: Group at a glance
I - Ye wi 43 Owned + k= la 9,395 Owned & 64% Occupancy 751,668 / day ARPOB! 540,881 In-patients vd R <> 3 86,768 Mio ; ¥ 21,331 Mio 24.6% 5 Managed Managed IEE H ital Bed 353,232 / day i et osptals meds _inQ423 HE p= Hom Bs 1 ° 22 i) Ambulatory 562 1,700+ 343 111 120 | i care & Birthing Beds Diagnos
Slide 6: Highlights Q4FY23
Highlights Q4FY23 7 Y Consolidated Revenues at 343,022 Mio for Q4FY23 growth of 21%. (e] ¥ 21,946 Mio ¥ 5,347 Mio Consolidated EBITDA before 247 operating cost at ¥7,056 Mio [e] 247 costs at 32,174 Mio including Non Cash ESOP Charge of 3281 Mio. [e] Consolidated PAT of 31,445 Mio. [e] 3,085 Mio T 25
Slide 7: Financials
a i Financials > Sa
Slide 8: Consolidated Financials Q4 FY23
Consolidated Financials Q4 FY23 2; (X mio) Healthcare Diagnostics & Sete! eel | Services Retail Health |HAEMUELS) Cong Note 1 : Blsuibiton Covid Vaccination revenues in Q4 FY22 Total Revenues 21,946 3,085 17,992 43,022 . EBITDA {Post Ind AS 116) {Pre 24|7 Cost) 5,347 255 1,453 7,056 Hospitals : ¥ 84
Slide 9: Consolidated Financials FY23
Consolidated Financials FY23 Healthcare Diagnostics & BIE (lel Note 1: Services Retail Health UEDGIEr) Distribution Covid Vaccination revenues in FY22 Total Revenues 86,768 12,311 67,045 166,125 Hospitals : ¥ 3,217 mio EBITDA (Post Ind AS 116) (Pre 24|7 Cost) 21,331 1,182 5,338 27,851 Clinics: 3% 1,
Slide 10: Healthcare Services
TT 4 2 Healthcare Services ewe Sa
Slide 11: Consolidated Healthcare Services Performance Q4FY23
Consolidated Healthcare Services Performance Q4FY23 2; (X mio) ’ Healthcare Serv a ew 8 Healthcare Serv IP Volume grew by 16% from 115,902 in Q4FY22 to Group (Mature) Others) Group 133,991 in Q4FY23. No of Hospitals 29 14 43 Operating beds 5476 2384 7860 Revenue grew by 18% excluding covid vaccinati
Slide 12: Consolidated Healthcare Services Performance FY23
Consolidated Healthcare Services Performance FY23 2; (X mio) i ’ Healthcare Serv Healthcare Serv)’ © ip (Newg& | Tiealtheare Serv JP Volume grew by 18% from 460,152 in FY22 to Others) Group 540,881 in FY23. No of Hospitals 29 14 43 Operating beds 5476 2384 7860 Revenue grew by 13%YoY excluding covid
Slide 13: Region wise Operational Parameters
Region wise Operational Parameters 2; ’ Total® Tamilnadu Region AP, Telengana Region (Hyderabad (Chennai & others) & others) © . » Particulars FY 22 FY23 yoy(%) FY22 FY23 vyoy(%) FY22 FY23 yoy (%) [| FY23 ARPOB in Metro cities at No. of Operating beds 7,875 7,860 2,131 2,112 1,344 1,207 ¥ 61,129 and
Slide 14: Diagnostics & Retail Health
TU 4 i Diagnostics & Retail Health tonnes py.
Slide 15: Executive Summary
cutive Summary 2; 7 » Network grew by 37% in FY23 from 468 touchpoints in FY22 to 641 touchpoints in FY23 Primary » Health checks and Consultations volumes grew by 50% and 30% respectively YoY in FY23 Care » Focus on strengthening omni-channel service offerings for delivering continuum of care » Dia
Slide 16: Financial Performance Q4FY23
Financial Performance Q4FY23 By (X mio) Q4 FY23 Clinics Diagnostics Sugar Dental Dialysis Cradles (IP) IVF Spectra (IP) NetWork Ea 1750 St 23 iE8 2 1 i BB AHLL Core Revenues (excluding Covid Footfalls/Day* 2,833 12,410 444 226 1,749 48 36 65 Vaccination. Covid Testing and Gross ARPP (Rs.}* 1,844 795
Slide 17: Financial Performance FY23
Financial Performance FY23 2; 4] (X mio) FY23 Clinics Diagnostics Sugar Dental Dialysis Cradles {IP) IVF Spectra (IP) . . Network 343 1,750 58 129 11 9 17 1 [| AHLL Core Revenues (excluding Covid Footfalls/Day* 4,920 12,154 714 316 1,649 47 33 72 Vaccination, Covid Testing and Isolation Gross ARPP (
Slide 18: Diagnostics: Key Parameters
Diagnostics : Key Parameters 3 7 Gross Revenue (INR Mn)? 3,827 EBITDA* (INR Mn)? Operational footprint (as of Mar 31, 2023) 14% 1,087 1,040 1,031 B Q4 FY22 om Q1 FY23 ‘a2 FY23 ‘a3 FY23 BE Q4 FY23 FY22 FY23 Q4 FY22* Q1FY23 Q2FY23 Q3FY23 Q4FY23 FY23 mB Gross Revenue Non Covid (Rs. Mn) ~~ m Gross Reven
Slide 19: Digital Health & Pharmacy Distribution
TU 4 i Digital Health & Pharmacy Distribution : py.
Slide 20: India's Largest Omni-Channel Healthcare Platform
India’s Largest Omni-Channel Healthcare x Apollo HealthCo Ltd (AHL) Apollo 247 Digital Platform Apollo Pharmacy Platform Added As at Mar 31,2023 FY 23 1.151 Doctors FY 23 Registrations Daily Active Users ————@ Chandigarh: 5 Virtual Doctor Consultation Daily Consultation Himachal Pradesh: 4 @———@ 6,5
Slide 21: Health Co Financials Q4 FY23
Health Co Financials Q4 FY23 2 )_{ . Online Pharmacy . . Offline Pharmacy go TotalHealth o Q4 delivered GMV : Rs 593 cr (9% higher vs Q3’ FY23) Distribution Co Apollo 247 Total Revenues 15,452 2,539 17,992 o March run rate of ~56K/day transactions across Pharma, Diagnostics, EBITDA (Post Ind AS 116)
Slide 22: Health Co Financials FY23
Health Co Financials FY 23 2; ’ Online Pharmacy Key milestones : Digital Business Offline Pharmacy a , Total Health Co Distribution & Distribution Apollo 247 Co o Digital platform delivered GMV : Rs 1,643 cr in FY 23, with YoY growth of 266% over FY 22. New business segment IP/OP launched Total Reve
Slide 23: Annexure
Annexure
Slide 24: Basis of Consolidation
Basis of Consolidation AHEL AHEL Standalone Hospitals {100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services 100.00% Tondiarpet - Chennai Chennai Apollo Hea
Slide 25: Ind AS 116 Impact on P&L and Balance Sheet - FY23
ND AS - 116 : Impact on P&L and Balance Sheet — FY23 | Asset as of 31st as o 31st Equity AHEL Standalone (post IND AS 116) Right of use zje Mar, 20234 Lease liabilities Mar, 2023 [LAE Revenue Ol SEES (Lease rent) EBITDA Amortisation eer 4 Profit & Loss : 4 ] VET 849 EEEZT [mers AHEL Consolidated (po
Slide 26: Thank you!
x Thank you !
Apollo Hospitals Enterprise — Q4 FY23 Earnings Presentation on 6ix